基本信息
浏览量:6
职业迁徙
个人简介
Mark has worked on economic evaluations of a range of technologies including heart disease and various cancers. He has also contributed to methods in the field, in particular relating to decision analytic modelling and handling uncertainty.
Mark was a member of the National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Committee between 2004 and 2008, the NICE Public Health Interventions Advisory Committee between 2006 and 2009 and currently sits on the NICE Diagnostics Advisory Committee. He chaired NICE's 2004 Task Group on methods guidance for economic evaluation and was a member of the Methods Working Party for the 2008 update of this guidance. He was a member of the Commissioning Board for the UK NHS Health Technology Assessment Programme between 2007 and 2010, and currently participates in the UK NIHR/Medical Research Council’s Methodology Panel. Mark is currently President-Elect of the International Society of Pharmacoeconomics and Outcomes Research.
Mark was a member of the National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Committee between 2004 and 2008, the NICE Public Health Interventions Advisory Committee between 2006 and 2009 and currently sits on the NICE Diagnostics Advisory Committee. He chaired NICE's 2004 Task Group on methods guidance for economic evaluation and was a member of the Methods Working Party for the 2008 update of this guidance. He was a member of the Commissioning Board for the UK NHS Health Technology Assessment Programme between 2007 and 2010, and currently participates in the UK NIHR/Medical Research Council’s Methodology Panel. Mark is currently President-Elect of the International Society of Pharmacoeconomics and Outcomes Research.
研究兴趣
论文共 552 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kathryn Abel,Emily Agnew,James Amos, Natalie Armstrong,Darius Armstrong-James, Thomas Ashfield,Stephen Aston,J Kenneth Baillie, Steven Baldwin,Gavin Barlow, Victoria Bartle, Julia Bielicki,
The Lancet Microbe (2024)
HEALTH ECONOMICSno. 4 (2024): 804-819
Nancy J. Devlin,Tianxin Pan,Mark Sculpher,Mark Jit,Elly Stolk,Donna Rowen, Barend van Hout,Richard Norman
PharmacoEconomicsno. 10 (2023): 1165-1174
C. Bowlus,C. Levy,K.V. Kowdley, N. Kachru, A. Kaushik, S. Jeyakumar, Y. Rodriguez-Guadarrama, N. Smith,A. Briggs,M. Sculpher, D. Ollendorf
Value in Healthno. 6 (2023): S70-S70
引用0浏览0引用
0
0
引用0浏览0WOS引用
0
0
Joseph Mfutso-Bengo, Faless Jeremiah, Florence Kasende-Chinguwo, Wingston Ng’ambi,Nthanda Nkungula,Isabel Kazanga-Chiumia, Mercy Juma,Marlen Chawani,Jobiba Chinkhumba,Pakwanja Twea, Emily Chirwa, Kate Langwe,
BMC Health Services Researchno. 1 (2023): 1-13
Health economics, policy, and lawpp.1-21, (2023)
引用1浏览0WOS引用
1
0
Ijeoma Edoka,Carleigh Krubiner, Andrew Mirelman,R. Brett McQueen,Mark Sculpher, Julia F. Slejko, Tommy Wilkinson
Oxford University Press eBookspp.213-238, (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn